Join
Live feed
·
PRReleasevia Quantisnow
Kyverna Therapeutics Inc. logo

Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026

ByQuantisnow·Wall Street's wire, on your screen.
KYTX· Kyverna Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KYTX (Kyverna Therapeutics Inc.) and more on Quantisnow.